Companies: 10,795·Total market cap: $144.5T
Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

PACBNASDAQHealthcare● Active
$1.35
$-0.10(-6.90%)
Market Cap$419312279
P/E Ratio
52W High$2.73
52W Low$0.99
Overview

Pacific Biosciences of California, Inc. (PACB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PACB · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

12

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Pacific Biosciences of California, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PACB insider buying and selling by quarter

PACB insider selling · PACB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
7.5M3.8M0
2025 Q2
2025 Q3
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · PACB ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PACB executive sell shares · PACB board member insider trading · PACB insider trading SEC filing

Showing 59 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Gibson Christopher

Director

Award

Date

Apr 8

Shares

57,473

Price

Value

View Form 4 on SEC.gov

Gibson James R II

See Remarks

Sale

Date

Apr 1

Shares

88,185

Price

$1.37

Value

$121K

View Form 4 on SEC.gov

Gibson Christopher

Director

Award

Date

Mar 3

Shares

53,913

Price

Value

View Form 4 on SEC.gov

HENRY CHRISTIAN O

See Remarks

Sale

Date

Mar 3

Shares

12,497

Price

$1.51

Value

$19K

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Sale

Date

Mar 3

Shares

6,504

Price

$1.51

Value

$10K

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Sale

Date

Mar 3

Shares

2,979

Price

$1.51

Value

$5K

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Award

Date

Feb 27

Shares

89,835

Price

Value

View Form 4 on SEC.gov

Gibson James R II

See Remarks

Award

Date

Feb 27

Shares

333,848

Price

Value

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Award

Date

Feb 27

Shares

500,000

Price

Value

View Form 4 on SEC.gov

HENRY CHRISTIAN O

See Remarks

Award

Date

Feb 27

Shares

920,810

Price

Value

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Sale

Date

Feb 17

Shares

129,790

Price

$1.58

Value

$205K

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Sale

Date

Feb 18

Shares

55,107

Price

$1.63

Value

$90K

View Form 4 on SEC.gov

HENRY CHRISTIAN O

See Remarks

Sale

Date

Feb 17

Shares

331,793

Price

$1.58

Value

$523K

View Form 4 on SEC.gov

HENRY CHRISTIAN O

See Remarks

Sale

Date

Feb 18

Shares

140,874

Price

$1.63

Value

$229K

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Sale

Date

Feb 17

Shares

35,215

Price

$1.58

Value

$55K

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Sale

Date

Feb 18

Shares

14,952

Price

$1.63

Value

$24K

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Sale

Date

Aug 18

Shares

26,836

Price

$1.31

Value

$35K

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Sale

Date

May 19

Shares

5,195

Price

$1.00

Value

$5K

View Form 4 on SEC.gov

Gibson James R II

See Remarks

Award

Date

Mar 31

Shares

1,000,000

Price

Value

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Award

Date

Mar 19

Shares

89,835

Price

Value

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Award

Date

Mar 19

Shares

449,176

Price

Value

View Form 4 on SEC.gov

HENRY CHRISTIAN O

See Remarks

Award

Date

Mar 19

Shares

920,810

Price

Value

View Form 4 on SEC.gov

HENRY CHRISTIAN O

See Remarks

Sale

Date

Mar 3

Shares

12,497

Price

$1.41

Value

$18K

View Form 4 on SEC.gov

Van Oene Mark

See Remarks

Sale

Date

Mar 3

Shares

6,486

Price

$1.41

Value

$9K

View Form 4 on SEC.gov

Farmer Michele

See Remarks

Sale

Date

Mar 3

Shares

2,973

Price

$1.41

Value

$4K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PACB insider trading

PACB insider trades

Pacific Biosciences of California, Inc. (PACB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Van Oene Mark (See Remarks), HENRY CHRISTIAN O (See Remarks), Farmer Michele (See Remarks). Over the past 12 months, 5 insiders have filed transactions with the SEC. PACB insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Pacific Biosciences of California, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

PACB insider trading · 5 questions

The insiders of Pacific Biosciences of California, Inc. (PACB) include executives and directors such as Van Oene Mark (See Remarks), HENRY CHRISTIAN O (See Remarks), Farmer Michele (See Remarks), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PACB board member insider tradingwho are PACB insidersPACB insider rosterPacific Biosciences of California, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026